Raz S

Eleusis Health Solutions US, New York, NY, USA.

3 papers

ArticleLSD

Perceptions of safety, subjective effects, and beliefs about the clinical utility of lysergic acid diethylamide in healthy participants within a novel intervention paradigm: Qualitative results from a proof-of-concept study.

Hendricks PS, Copes H, Family N +3

Europe PMC2022
ArticleLSD

Safety, tolerability, pharmacokinetics, and subjective effects of 50, 75, and 100 µg LSD in healthy participants within a novel intervention paradigm: A proof-of-concept study.

Family N, Hendricks PS, Williams LT +4

Europe PMC2022
ArticleLSD

Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers.

Family N, Maillet EL, Williams LTJ +6

Europe PMC2020